Elizabeth A. Barrett, Chief Executive Officer at UroGen Pharma Ltd. (URGN), sold 8,195 shares at $7.58 ($62K) on 2022-01-31, disclosed to the SEC on 2022-02-02.
Open-market sale of $62k URGN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.58 | 2,235 | $17K | 27.3% |
| 2 | $7.58 | 5,960 | $45K | 72.7% |
| Total | $7.58 avg | 8,195 | $62K | 100% |
| Filing → |
| URGN | BUY | 2019-11-22 | $209K | — | Filing → |
| URGN | BUY | 2019-11-22 | $211K | — | Filing → |
| URGN | BUY | 2019-11-18 | $40K | — | Filing → |